The discussions reflect a moderate curiosity about genetic factors, with statements like 'it's saying that even in people with genes for less effective CYP2D6, MDMA gets metabolized through other pathways,' which clarifies misconceptions. The tone is analytical, and the language used indicates respondents are interested in understanding the practical relevance of pharmacogenetics, but the overall impact remains modest.
AgreementModerate agreement
Most discussions align with the article's conclusion that CYP2D6's role in drug metabolism is less clinically significant than lab studies suggest.
InterestModerate interest
Participants show moderate interest, primarily focused on the genetic enzyme CYP2D6 and its role in drug processing.
EngagementModerate engagement
The comments demonstrate some engagement, especially in clarifying whether genetics influence drug effects in real life.
ImpactNeutral impact
The conversations do not suggest a huge impact of the publication on broader drug treatment or policy debates, but rather a clarification of specific pharmacogenetic implications.
Abstract in brief
In vitro studies show that the metabolism of methamphetamine and MDMA is mainly regulated by the enzyme CYP2D6, with MDMA acting as a potent inhibitor that can make users behave as if they have a poor metabolizer genotype.
Despite the strong interaction seen in lab studies, in real-life scenarios, other enzymes and kidney excretion also play significant roles in breaking down these drugs, which lessens the impact of CYP2D6 genetic differences on drug effects.
Overall, the actual clinical importance of CYP2D6 genetic variation in how people process methamphetamine and MDMA is less significant than previously thought based on lab data, meaning genetics might not predict individual responses as strongly as expected.]
#MDMA, #methamphetamine, and CYP2D6 #pharmacogenetics: what is clinically relevant? https://t.co/DwJGLepkBf
Feb 27, 2019 · 1 like · 2,507 followersView post →
SM
Sarah McManus
@SarahAMcManus · X
@daleth27 @saul_mondriaan @rahtlufolek Is this about genes for the liver enzyme CYP2D6?
This paper is pretty dense, but as far as I can tell it's saying that even in people with genes for less effective CYP2D6, MDMA gets metabolized through other pathways & it's not that clinically relevant
https://t.co/23lAe1ppn4
This video explains what MDMA is, its history, effects, and how the body metabolizes it. It covers MDMA's synthesis, use as a recreational drug, and the nonlinear metabolism influenced by self-inhibition, affecting…
This video explores the role of CYP2D6 enzyme in metabolizing methamphetamine and MDMA, highlighting how genetic variations impact drug processing. It emphasizes the differences between laboratory findings and real-life…
@daleth27 @saul_mondriaan @rahtlufolek Is this about genes for the liver enzyme CYP2D6?
This paper is pretty dense, but as far as I can tell it's saying that even in people with genes for less effective CYP2D6, MDMA gets metabolized through other pathways & it's not that clinically relevant
https://t.co/23lAe1ppn4
polarization delivers secretory granules to the immunological synapse. doi:10.3389/fimmu.2012.00235 Nature (2006) 443:462–5. ... gene products in T cell functions ...
... 10.3389/fnint.2012.00005. Cook, S., Kokmotou, K., Soto, V., Fallon, N., Tyson ... 2012.00235. Cela-Conde, C. J., Agnati, L., Huston, J. P., Mora, F ...
Frontiers in Ecology and Evolution, 3. https://doi.org/10.3389/fevo.2015.00091 ... 185X.2012.00235.x. 200. GLOBAL SYMPOSIUM ON SOIL BIODIVERSITY | FAO HQ ...